04/08
|
Science Central features caffeine's potential role in skin cancer prevention.
Dr. Nghiem was interviewed by Science Central for his work on caffeine and skin cancer. Click here to see the video interview. |
| 04/08 |
Collaborative research with Dr. Allan Conney at Rutgers University yields insight into the mechanism of caffeine's protective effects after UV damage in mouse skin.
A study looking at the effects of caffeine on the inhibition of the ATR/Chk1 pathway is published in Cancer Research. They found that administration of caffeine to mice enhances clearance of DNA-damaged cells after treatment with UV. [pdf] |
| 03/08 |
Dr. Nghiem is feature in the Seattle Post-Intelligencer Newspaper.
Dr. Nghiem is featured on the cover of the Seattle PI Saturday Newspaper discussing his research on the role of topical caffeine in preventing skin cancer in mice.
click here to read the article |
| 07/07 |
Ashley Warcola joins the lab.
Ashley Warcola joins the lab as a research assistant. She is returning to Seattle after graduating from the University of Portland and spending a year in a physiology lab at OHSU. She has projects on both the replication checkpoint and Merkel cell carcinoma.
Kelly Garneski (left) teaches Ashley Warcola (right) about the function of trypsin. |
| 06/07 |
John Pylman joins the lab for the summer.
John Pylman, M.S. joins the lab as a research assistant. He is a fourth-year M.D./M.P.H. candidate at George Washington University, focusing on Merkel cell carcinoma investigations at the Nghiem laboratory. |
| 05/07 |
The role of topical caffeine after UV in protecting from photodamage is described.
Drs. Koo, Kawasumi and Nghiem publish their findings in the British Journal of Dermatology. [pdf]
|
| 02/07 |
Erin Higgins joins the lab.
Erin Higgins joins the lab as an undergraduate lab assistant. She is a student at the University of Washington, where she is pursuing degrees in Microbiology and Spanish. |
| 08/06 |
Kelly Garneski joins the lab.
Kelly Garneski, an MSTP student, joined the lab for the summer and chose the Nghiem lab for her PhD thesis work. She has extensive research experience and will be studying the biology of Merkel Cell Carcinoma. |
| 07/06 |
Bianca Lemos joins the lab.
Bianca Lemos, MD, joins the lab after completing her Medicine internship at the University of Washington. She will be focusing on the effect of inhibiting the replication checkpoint on UV-induced carcinogenesis and will participate in maintaining the Merkel cell carcinoma database. |
| 04/06 |
Protein Kinases and Cancer Therapy featured in Oncogenomics textbook. This chapter provides an overview of new and emerging approaches to target protein kinases in cancer therapy. [pdf] |
| 03/06 |
Paul Nghiem, MD, PhD, is featured in an article in the March 1, 2006, issue of Dermatology Times |
| 01/06 |
The Nghiem Lab moves to Seattle.
Dr. Nghiem moves his lab to the University of Washington in Seattle, Washington. Dr. Kawasumi will join him in Seattle in the Fall, and Dr. Heffernan will remain a part of the lab but will physically remain in Boston. New lab members beginning in the summer include Michelle Heath, MD, and Bianca Lemos, MD. Dr. Heath is a Dermatology fellow working with the Merkel Cell Carcinoma database. Dr. Lemos is a research fellow working on UV carcinogenesis in ATR-deficient mice. |
| |
|
| |
Seattle Skyline and the Space Needle |
| 04/05 |
Tim Heffernan, PhD, from UNC Chapel Hill, joins the lab
Dr. Heffernan did his PhD with William Kaufmann in North Carolina on the replication checkpoint and ultraviolet-induced DNA damage. He brings extraordinary expertise in this field to our lab. He is working on the roles of ATR and Chk1 in the response to UV damage in mouse and human cells.
|
| 08/04 |
Merkel Cell Carcinoma
website launched.
This website will serve as a
unique resource for Merkell cell carcinoma patients and their physicians.
Written and conceived together
with Sheela Gupta and Linda Wang and implemented by Digizyme,
Inc.
Click here
to view website. |
| 06/04 |
Adam Chen, junior at Tufts University, joins
the lab for the summer.
Adam is a junior at Tufts University majoring in Biology. He will be responsible
for maintaining our transgenic mice and focusing on carcinogenesis. |
06/04 |
Douglas Levine, senior at MIT, joins the lab
full time.
Douglas is a senior at MIT majoring in Biology. He will be working on the
transgenic mouse project with a focus on primary keratinocytes. |
| 04/04 |
Masaoki Kawasumi, MD, PhD, from Keio University,
joins the lab.
Dr. Kawasumi is working on the development small molecule inhibitors of
ATR. |
| 01/04 |
A key role for ATR in HIV biology.
In an ongoing collaboration with Dr. Vicente Planelle's laboratory, ATR has been shown to play a key role in the cellular response to HIV-1 infection in two papers. [MCB 2004] & [JBL 2003] |
09/03
|
Sang-Wahn Koo, MD, PhD, dermatologist
and scientist joins the lab.
Dr. Koo was Assistant Professor of Dermatology in Korea, and has done post-doctoral
work for the past three years in the USA. |
| 09/03 |
Five-year NIH Grant Awarded to the lab: "The
Replication Checkpoint and Genomic Fidelity in Skin."
This proposal to study the replication checkpoint and small molecules to
regulate it, was rated in the top 4.8% of grants submitted to the Chemical
Pathology Study Section of the NIH. It will provide critical funding
for our studies through 2008. |
| 08/03 |
Rapamycin and nutrient signaling are profiled in a review with
Aly Shamji and Stuart Schreiber. [pdf] |
| 12/02 |
Essential role for ATR in the regulation of
chromosomal fragile sites described in Cell.
Through an ongoing collaboration with Anne Casper and the laboratory of
Thomas Glover at University of Michigan, a key role of ATR was unraveled.
[pdf] |
| |
|
